Fatty liver disease is an increasingly prevalent health issue that often remains undetected until it leads to severe ...

Liver cancer in the Philippines holds a staggering mortality rate of 11.6 out of 100,000 individuals, compared to the global death rate of 7.8/100,000. This reflects the significant impact of liver ...

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD) ...

Hepatic biliary adenofibroma (BAF) is a rare benign bile duct neoplasm that has garnered increasing attention due to its potential role as a precursor lesion for intrahepatic cholangiocarcinoma (iCCA) ...

One of the world's most globally recognised liver cancer treatments will receive public funding from today. Tecentriq ...

北京时间2025年2月22日，中国科学院院士、东南大学附属中大医院滕皋军教授联合国内外专家学者，在医学领域国际顶级期刊Lancet Gastroenterology & Hepatology发表了题为“Combination Locoregional ...

New Zealanders now have funded access to a global standard of care treatment for a form of liver cancer, Hepatocellular Carcinoma (HCC), which, unlike many other cancers has a rapidly increasing rate ...

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is a global health ...

Immune-Onc Therapeutics has dosed the first subject in the Phase Ib/II trial of IO-108 plus Roche’s atezolizumab and ...

Spleen volume was linked with an increased risk of IBD in a Mendelian randomization study. (Scientific Reports) A dual ...